序号 |
标题 |
次数 |
作者 |
发布时间 |
145306 |
Cas:125411-99-6 ,乙基-2,3,4,6-O-四苄基-β-D-硫代半乳糖苷 |
189 |
zyl |
2024-06-04 |
145307 |
含TpSD COF的罗丹明B (RhB)溶液 COFs定制 |
194 |
kx |
2024-06-04 |
145308 |
双发射硼染料立体络合PLA-PEG纳米粒子 |
232 |
wyh |
2024-06-04 |
145309 |
cas:52645-73-5, 乙基-2,3,4,6-O-四乙酰基-a-D-1-硫代吡喃葡萄糖苷 |
169 |
zyl |
2024-06-04 |
145310 |
COF复合材料(Ni-TpBpy)的关键特性 COFs定制 |
364 |
kx |
2024-06-04 |
145311 |
cas:161007-96-1, 4,6-O-苄叉-1-硫代-b-D-对甲基苯基吡喃半乳糖苷 |
197 |
zyl |
2024-06-04 |
145312 |
mannose-PEG-Paclitaxel,甘露糖聚乙二醇紫杉醇,Paclitaxel-PEG-mannose,PEG分子量按需定制 |
173 |
axc |
2024-06-04 |
145313 |
PLA-PEG-PLA END-CAPPED WITH METHACRYLOYL GROUPS |
193 |
wyh |
2024-06-04 |
145314 |
galactose-PEG-Paclitaxel,半乳糖聚乙二醇紫杉醇,Paclitaxel-PEG-galactose,MW:2000/3400/5000 |
170 |
axc |
2024-06-04 |
145315 |
Cas:74801-29-9 ,苯基-2,3,4,6-O-四苄基-β-D-硫代半乳糖苷 |
164 |
zyl |
2024-06-04 |
145316 |
β-酮胺基COF:TP-EDDA-COF和TP-BDDA-COF 齐岳定制 |
328 |
kx |
2024-06-04 |
145317 |
甲基丙烯酰基封端的PLA-PEG-PLA的制备过程 |
222 |
wyh |
2024-06-04 |
145318 |
TAPP-Co-COF TAPP-Fe-COF TAPP-Ni-COF COFs定制 |
214 |
kx |
2024-06-04 |
145319 |
516 - D0870-LOADED PLA-PEG NANOPARTICLES |
148 |
wyh |
2024-06-04 |
145320 |
Chitosan-PEG-Paclitaxel,壳聚糖聚乙二醇紫杉醇,Paclitaxel-PEG-Chitosan,MW:350/550/750 |
154 |
axc |
2024-06-04 |
145321 |
TAPP-H-COF 基于卟啉的COFs(TAPP-x-COF) COFs定制 |
177 |
kx |
2024-06-04 |
145322 |
Dextran-PEG-Paclitaxel,葡聚糖聚乙二醇紫杉醇,Paclitaxel-PEG-Dextran,分子量按需定制 |
193 |
axc |
2024-06-04 |
145323 |
516-D0870-负载PLA-PEG纳米颗粒 |
145 |
wyh |
2024-06-04 |
145324 |
OVA-PEG-Paclitaxel,卵清蛋白聚乙二醇紫杉醇,Paclitaxel-PEG-OVA,PEG分子量按需定制 |
190 |
axc |
2024-06-04 |
145325 |
核壳磁性共价有机框架(COF)材料 齐岳定制 |
237 |
kx |
2024-06-04 |
145326 |
cas:41670-79-5, 乙基-2,3,4,6-O-四乙酰基-a-D-1-硫代吡喃葡萄糖苷 |
140 |
zyl |
2024-06-04 |
145327 |
hydrophilic paclitaxel-loaded PLA-PEG-PLA |
173 |
wyh |
2024-06-04 |
145328 |
ConA-PEG-Paclitaxel,刀豆球蛋白A聚乙二醇紫杉醇,Paclitaxel-PEG-ConA,MW:2000/3400/5000 |
168 |
axc |
2024-06-04 |
145329 |
cas:10227-19-7 ,5-硫代-D-葡萄糖, 5-Thio-D-glucose |
261 |
zyl |
2024-06-04 |
145330 |
亲水性紫杉醇负载PLA-PEG-PLA |
180 |
wyh |
2024-06-04 |
145331 |
共价有机框架(COF-960-n) COFs定制 |
149 |
kx |
2024-06-04 |
145332 |
Tf-PEG-Paclitaxel,转铁蛋白聚乙二醇紫杉醇,Paclitaxel-PEG-Tf,MW:350/550/750 |
150 |
axc |
2024-06-04 |
145333 |
cas:55722-49-1, 2,3,4,6-O-四乙酰基-1-硫代-β-D-乙基半乳糖苷 |
183 |
zyl |
2024-06-04 |
145334 |
Nisin-Loaded PLA-PEG-PLA Nanoparticles |
140 |
wyh |
2024-06-04 |
145335 |
HSA-PEG-Paclitaxel,人血清白蛋白聚乙二醇紫杉醇,Paclitaxel-PEG-HSA,分子量按需定制 |
181 |
axc |
2024-06-04 |
145336 |
Nisin负载的PLA-PEG-PLA纳米粒子 |
187 |
wyh |
2024-06-04 |
145337 |
cas:63407-54-5, 2-苯乙基-β-D-硫代半乳糖苷 |
177 |
zyl |
2024-06-04 |
145338 |
氨基连通的COF,KUF-2和KUF-3 齐岳定制合成 |
256 |
kx |
2024-06-04 |
145339 |
BSA-PEG-Paclitaxel,牛血清白蛋白聚乙二醇紫杉醇,Paclitaxel-PEG-BSA,PEG分子量按需定制 |
168 |
axc |
2024-06-04 |
145340 |
Graphene oxide stabilized by PLA-PEG copolymers |
160 |
wyh |
2024-06-04 |
145341 |
cas:41670-79-5, 乙基-2,3,4,6-O-四乙酰基-a-D-1-硫代吡喃葡萄糖苷 |
186 |
zyl |
2024-06-04 |
145342 |
PLA-PEG共聚物稳定氧化石墨烯(GO) |
162 |
wyh |
2024-06-04 |
145343 |
TpPa-SO3H@TpTTPA(X) COFs定制 |
155 |
kx |
2024-06-04 |
145344 |
cas:10227-19-7 ,5-硫代-D-葡萄糖, 5-Thio-D-glucose |
152 |
zyl |
2024-06-04 |
145345 |
HA-PEG-Paclitaxel,透明质酸聚乙二醇紫杉醇,Paclitaxel-PEG-Ha,MW:2000/3400/5000 |
171 |
axc |
2024-06-04 |
145346 |
Intravenous delivery of Erlotinib-loaded PLA-PEG nanoparticles |
181 |
wyh |
2024-06-04 |
145347 |
cas:63407-54-5, 2-苯乙基-β-D-硫代半乳糖苷 |
202 |
zyl |
2024-06-04 |
145348 |
TpTTPA纳米带 共价有机框架(COFs) COFs定制 |
230 |
kx |
2024-06-04 |
145349 |
DMG-PEG-Paclitaxel,二肉豆蔻酰-sn-甘油聚乙二醇紫杉醇,Paclitaxel-PEG-DMG,MW:350/550/750 |
184 |
axc |
2024-06-04 |
145350 |
cas:41670-79-5, 乙基-2,3,4,6-O-四乙酰基-a-D-1-硫代吡喃葡萄糖苷 |
160 |
zyl |
2024-06-04 |